USP14 and cancer: Knockdown of USP14 or treatment with a USP14-specific inhibitor (IU1) (Fig. S3a) led to significantly increased BAG4 ubiquitination levels in cancer cells (Fig. 4c, d), implying that USP14 normally functions to deubiquitinate BAG4 and prevent its degradation.